photo of Dr Claire von Mollendorf

Dr Claire von Mollendorf

Dr Claire von Mollendorf

Details

Role Team Leader / Senior Research Fellow
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an...
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.

Top Publications

  • Fagerli, K, Ulziibayar, M, Suuri, B, Luvsantseren, D, Narangerel, D, Puversuren, B, Tholmon, B, Gessner, BD, Dunne, EM, Grobler, AC, et al. Epidemiology of pneumonia in hospitalized adults ≥18 years old in four districts of Ulaanbaatar, Mongolia, 2015–2019. The Lancet Regional Health - Western Pacific 100591 2022
    view publication
  • Wilkes, C, Graham, H, Walker, P, Duke, T, Duke, T, Graham, H, Graham, S, Gray, A, Gwee, A, von Mollendorf, C, et al. Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries. Journal of Global Health 12: 10008 2022
    view publication
  • Hume-Nixon, M, Graham, H, Russell, F, Mulholland, K, Gwee, A, Duke, T, Graham, H, Graham, S, Gray, A, Gwee, A, et al. Review of the role of additional treatments including oseltamivir, oral steroids, macrolides, and vitamin supplementation for children with severe pneumonia in low- and middle-income countries. Journal of Global Health 12: 10005 2022
    view publication
  • Hume-Nixon, M, Lim, R, Russell, F, Graham, H, von Mollendorf, C, Mulholland, K, Gwee, A, Duke, T, Graham, H, Graham, S, et al. Systematic review of the clinical outcomes of pneumonia with a penicillin-group resistant pneumococcus in respiratory and blood culture specimens in children in low- and middle-income countries. Journal of Global Health 12: 10004 2022
    view publication
  • von Mollendorf, C, Berger, D, Gwee, A, Duke, T, Graham, SM, Russell, FM, Mulholland, EK, Duke, T, Graham, H, Graham, S, et al. Aetiology of childhood pneumonia in low- and middle-income countries in the era of vaccination: a systematic review. Journal of Global Health 12: 10009 2022
    view publication

Page 1 of 14

Professional activities